30.100
+2,03%
2026-10-19
Fundamental Analysis
41 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -24.0% | +4.4% | 1 / 3 | -3.0% | -1.60 pp | -4.31 pp | +30.1% | 0.04 | 5.48 | 133 | −3,0% | 20,7 | −24,0% | 5.48 | 7.74 | −29,2% |
| Pts | 0 | 0 | 4 | 0 | 4 | 0 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 30.100 (close price on 2026-10-19)EPS (TTM): 5.496
Financial charts
1.Revenue & growth
VND bn133Q2/26
1.Revenue & growth
VND bn133Q2/26
2.Profit & growth
VND bn20,7Q2/26
3.Profit mix (Penman)
VND bn103Q2/26
4.Margins & cost structure
%30.3%Q2/26
5.Returns & cash cycle
% · days40.0%Q2/26
6.Earnings quality & cash
VND bn41,6Q2/26
7.Asset structure
VND bn588Q2/26
8.Funding & debt health
VND bn · times588Q2/26
9.Revenue backlog
VND bn0,06Q2/26
10.Valuation
times · %5,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.377Q2/26
Adjusted EPS growth, latest quarter
-24.0%
Average adjusted EPS growth, 3 quarters
4.4%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26